139 related articles for article (PubMed ID: 8952270)
1. [A study of relapsed cases of vivax malaria after the standard primaquine therapy].
Kimura M; Tomizawa I; Takizawa Y; Ohtomo H
Kansenshogaku Zasshi; 1996 Oct; 70(10):1086-91. PubMed ID: 8952270
[TBL] [Abstract][Full Text] [Related]
2. Randomized, open-label trial of primaquine against vivax malaria relapse in Indonesia.
Sutanto I; Tjahjono B; Basri H; Taylor WR; Putri FA; Meilia RA; Setiabudy R; Nurleila S; Ekawati LL; Elyazar I; Farrar J; Sudoyo H; Baird JK
Antimicrob Agents Chemother; 2013 Mar; 57(3):1128-35. PubMed ID: 23254437
[TBL] [Abstract][Full Text] [Related]
3. Imported tertian malaria resistant to primaquine.
Na DJ; Han JD; Cha DY; Song IK; Choi HW; Chung EA; Park CW; Choi JS
Korean J Intern Med; 1999 Jul; 14(2):86-9. PubMed ID: 10461431
[TBL] [Abstract][Full Text] [Related]
4. Radical curative efficacy of five-day regimen of primaquine for treatment of Plasmodium vivax malaria in India.
Yadav RS; Ghosh SK
J Parasitol; 2002 Oct; 88(5):1042-4. PubMed ID: 12435158
[TBL] [Abstract][Full Text] [Related]
5. Plasmodium vivax relapses after 5 days of primaquine treatment, in some industrial complexes of India.
Dua VK; Sharma VP
Ann Trop Med Parasitol; 2001 Oct; 95(7):655-9. PubMed ID: 11784418
[TBL] [Abstract][Full Text] [Related]
6. High-dose primaquine regimens against relapse of Plasmodium vivax malaria.
Krudsood S; Tangpukdee N; Wilairatana P; Phophak N; Baird JK; Brittenham GM; Looareesuwan S
Am J Trop Med Hyg; 2008 May; 78(5):736-40. PubMed ID: 18458306
[TBL] [Abstract][Full Text] [Related]
7. Halofantrine and primaquine for radical cure of malaria in Irian Jaya, Indonesia.
Fryauff DJ; Baird JK; Basri H; Wiady I; Purnomo ; Bangs MJ; Subianto B; Harjosuwarno S; Tjitra E; Richie TL; Hoffman SL
Ann Trop Med Parasitol; 1997 Jan; 91(1):7-16. PubMed ID: 9093424
[TBL] [Abstract][Full Text] [Related]
8. Short report: primaquine-tolerant Plasmodium vivax in an Italian traveler from Guatemala.
Signorini L; Matteelli A; Castelnuovo F; Castelli F; Oladeji O; Carosi G
Am J Trop Med Hyg; 1996 Nov; 55(5):472-3. PubMed ID: 8940974
[TBL] [Abstract][Full Text] [Related]
9. Studies on Plasmodium vivax relapse pattern in Kheda district, Gujarat.
Srivastava HC; Sharma SK; Bhatt RM; Sharma VP
Indian J Malariol; 1996 Dec; 33(4):173-9. PubMed ID: 9125831
[TBL] [Abstract][Full Text] [Related]
10. A relapsed case of imported tertian malaria after a standard course of hydroxychloroquine and primaquine therapy.
Yi KJ; Chung MH; Kim HS; Kim CS; Pai SH
Korean J Parasitol; 1998 Jun; 36(2):143-6. PubMed ID: 9637832
[TBL] [Abstract][Full Text] [Related]
11. Regional differences in the response of Plasmodium vivax malaria to primaquine as anti-relapse therapy.
Goller JL; Jolley D; Ringwald P; Biggs BA
Am J Trop Med Hyg; 2007 Feb; 76(2):203-7. PubMed ID: 17297026
[TBL] [Abstract][Full Text] [Related]
12. Atovaquone and proguanil hydrochloride followed by primaquine for treatment of Plasmodium vivax malaria in Thailand.
Looareesuwan S; Wilairatana P; Glanarongran R; Indravijit KA; Supeeranontha L; Chinnapha S; Scott TR; Chulay JD
Trans R Soc Trop Med Hyg; 1999; 93(6):637-40. PubMed ID: 10717754
[TBL] [Abstract][Full Text] [Related]
13. Plasmodium vivax infections in U.S. Army troops: failure of primaquine to prevent relapse in studies from Somalia.
Smoak BL; DeFraites RF; Magill AJ; Kain KC; Wellde BT
Am J Trop Med Hyg; 1997 Feb; 56(2):231-4. PubMed ID: 9080885
[TBL] [Abstract][Full Text] [Related]
14. Safety and tolerability of elubaquine (bulaquine, CDRI 80/53) for treatment of Plasmidium vivax malaria in Thailand.
Krudsood S; Wilairatana P; Tangpukdee N; Chalermrut K; Srivilairit S; Thanachartwet V; Muangnoicharoen S; Luplertlop N; Brittenham GM; Looareesuwan S
Korean J Parasitol; 2006 Sep; 44(3):221-8. PubMed ID: 16969059
[TBL] [Abstract][Full Text] [Related]
15. Treatment of vivax malaria on the western border of Thailand.
Luxemburger C; van Vugt M; Jonathan S; McGready R; Looareesuwan S; White NJ; Nosten F
Trans R Soc Trop Med Hyg; 1999; 93(4):433-8. PubMed ID: 10674098
[TBL] [Abstract][Full Text] [Related]
16. Randomized trial of 3-dose regimens of tafenoquine (WR238605) versus low-dose primaquine for preventing Plasmodium vivax malaria relapse.
Walsh DS; Wilairatana P; Tang DB; Heppner DG; Brewer TG; Krudsood S; Silachamroon U; Phumratanaprapin W; Siriyanonda D; Looareesuwan S
Clin Infect Dis; 2004 Oct; 39(8):1095-103. PubMed ID: 15486831
[TBL] [Abstract][Full Text] [Related]
17. In-vivo sensitivity of Plasmodium vivax isolates from Rond nia (western Amazon region, Brazil) to regimens including chloroquine and primaquine.
Villalobos-Salcedo JM; Tada MS; Kimura E; Menezes MJ; Pereira da Silva LH
Ann Trop Med Parasitol; 2000 Dec; 94(8):749-58. PubMed ID: 11214093
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic efficacy of alternative primaquine regimens to standard treatment in preventing relapses by Plasmodium vivax: A systematic review and meta-analysis.
Zuluaga-Idarraga LM; Tamayo Perez ME; Aguirre-Acevedo DC
Colomb Med (Cali); 2015 Dec; 46(4):183-91. PubMed ID: 26848199
[TBL] [Abstract][Full Text] [Related]
19. Chloroquine sensitivity of Plasmodium vivax in Thailand.
Looareesuwan S; Wilairatana P; Krudsood S; Treeprasertsuk S; Singhasivanon P; Bussaratid V; Chokjindachai W; Viriyavejakul P; Chalermrut K; Walsh D S; White J
Ann Trop Med Parasitol; 1999 Apr; 93(3):225-30. PubMed ID: 10562823
[TBL] [Abstract][Full Text] [Related]
20. Primaquine ineligibility in anti-relapse therapy of Plasmodium vivax malaria: the problem of G6PD deficiency and cytochrome P-450 2D6 polymorphisms.
Baird JK; Battle KE; Howes RE
Malar J; 2018 Jan; 17(1):42. PubMed ID: 29357870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
